| Obligatory | Must not donate if: e) The donor declares a history of optic neuritis. |
| Discretionary | a) If chronic glaucoma treatment is with tablets or drops only, accept. b) Non-injection treatment for age-related macular degeneration (AMD), accept. c) Most donors with poor vision can be accepted but see 'Disabled Donor' if they are not able to read. d) If more than seven days from intravitreal injection treatment for age-related macular degeneration (AMD), accept. e) If completed course of any eye drops following surgery for a benign condition not requiring ocular tissue transplant and there is no active infection or inflammation, accept. |
| See if Relevant | Autoimmune Disease |
| Additional Information | Allogeneic (from another person) ocular tissue may be transplanted in operations other than corneal transplants, including surgery for glaucoma. If surgery was performed after 1997 and any transplanted ocular material was supplied through UK Transplant, this information will be stored on the National Transplant Database held by NHS Blood and Transplant. There is a risk of bacterial infection and other complications following injection treatment for age-related macular degeneration (AMD). This is why a seven day deferral is required. Intravitreal injection treatment for wet/age-related macular degeneration is with anti-vascular endothelial growth factor (anti-VEGF) therapy, these include Bevacizumab (Avastin® ), Ranibizumab (Lucentis®) and Pegaptanib sodium (Macugen®). |
| Information | Part of this entry is a requirement of the Blood Safety and Quality Regulations 2005. |
| Reason for change | An entry re Optic Neuritis has been added as well as a link to Central Nervous System Disease |
| Donor Information | If you wish to obtain more information regarding a personal medical issue please contact your National Help Line. |
This entry was last updated in:
DSG-WB Edition 203, Release 38 Issue 01